News | RIVM

Number of STI tests at sexual health centres are rising again

In 2021, more than 138,000 people were tested for sexually transmitted infections (STIs) at a centre for sexual health.

More STI tests conducted by Sexual Health Centres

In 2021, more people visited a Sexual Health Centre (SHC) to get tested for sexually transmitted infections (STIs) than in 2020. This figure is still lower than in 2019, the year before the coronavirus outbreak.

Discussion regarding health-based guidance value of PFOA

The European Food Safety Authority (EFSA) has published a provisional health-based guidance value for perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).

New standard for exposure assessment of cleaning products

RIVM has updated the standard for exposure assessment of cleaning products in the ConsExpo Cleaning Products Fact Sheet.

More gonorrhoea, syphilis and chlamydia at Dutch STI clinics

An increasing number of clients tested at a Dutch STI clinic for a sexually transmitted infection (STI) is diagnosed with gonorrhoea, syphilis and chlamydia.

RIVM launches new web-based version of ConsExpo

An improved version of the computer program ConsExpo is now available via the RIVM website.

The number of STI tests keeps increasing

The number of clients tested for sexually transmitted infections (STIs) at Dutch STI clinics has increased since 2004.

Improving consumer exposure assessment to chemical substances

By combining the available international knowledge, the method to assess the extent to which consumers are exposed to chemical substances via everyday products such as paint, cleaning agents and co

Is screening for sexually transmitted infections as part of HIV care cost-effective in the Netherlands?

Routine screening for anorectal chlamydia among HIV-positive men who have sex with men (MSM) could avert further spread of chlamydia and HIV in the total MSM population.

Regional differences in testing rates underestimate incidence of LGV epidemic

Until 2003, Lymphogranuloma venereum (LGV), an aggressive form of chlamydia, was considered to be a rare tropical disease, endemic to Africa, Asia and the Caribbean.